Many visual impairments cause visual symptoms with stroke survivors aware of blurred/altered vision or jumbled/double images. These visual symptoms cause impact to general function and to daily life ). However, a wide variety of interventions are available to aid and/or ameliorate these symptoms (Pollock et al., 2011a (Pollock et al., , 2011b (Pollock et al., , 2012 .
The purpose of this study was to profile the full range of visual disorders from a large, prospective, observation cohort study of stroke survivors with suspected visual impairment, referred by stroke multidisciplinary teams to orthoptic services.
| METHODS

| Study design and population
This prospective multicenter observational case cohort study comprised local orthoptic principal investigators from 20 UK hospital trusts responsible for assessing stroke patients and collecting patient data. Orthoptic services for stroke units in the UK provide comprehensive visual assessment at the bedside and typically initiate management options at this acute stage. Review visits continue on the stroke unit as needed and, subsequently, in out-patient eye clinics.
The data were collated centrally at the University of Liverpool. The study had multicenter ethical approval via the National Research Ethics Service (06/Q0904/5) and was undertaken in accordance with the Tenets of Helsinki.
The target population was stroke patients suspected of having a visual difficulty. Referrals could be made from in-patient wards, rehabilitation units, community services, or out-patient clinics. Patients were given an information sheet and recruited after informed, written consent. Patients were excluded if they were unable to consent due to cognitive impairment, unwilling to consent, if their diagnosis was that of transient ischemic attack or if they were discharged without vision assessment.
| Measures
Patients with suspected visual difficulty were identified using a screening form (Figure 1 : SPSS: RRID: SCR_002865). Subsequently this was used as the referral form to the Orthoptic service. A standardized investigation sheet was used for the eye assessment consisting of identification of known preexistent ocular pathology, symptoms and signs, investigation of visual field, ocular motility, and perceptual aspects (Rowe, 2011) . Visual fields were assessed qualitatively by traditional confrontation methods or quantitatively by Humphrey (Humphrey systems, Dublin, CA, USA) automated central and/or peripheral static perimetry or Goldmann/Octopus (Haag Streit Int, Switzerland) kinetic perimetry.
Visual acuity was assessed uniocularly at near and distance fixation with Snellen or logMAR acuity tests. Low visual acuity was considered in two categories. The first defined low visual acuity as less than best corrected 6/12 Snellens acuity or 0.3 logMAR in accordance with UK driving standards. The second defined low visual acuity as less than 6/18 Snellens acuity or 0.5 logMAR and equal or better than 3/60 Snellens acuity as per World Health Organisation (WHO) guidelines.
Assessment of ocular alignment and motility consisted of cover test, evaluation of saccadic, smooth pursuit and vergence eye movements, retinal correspondence (Bagolini glasses), fusional vergence (20D or fusional range), stereopsis (Frisby near test), prism cover test, and lid and pupil function.
Perceptual deficits were recorded after questioning of the patient and/or carers and relatives. Inattention was assessed by means of a combination of assessments including line bisection, Albert's test, cancellation tests, and memory tests using verbal description and drawing. Alexia was diagnosed where patients described an inability to read (despite being able to see the text) because of being unable to decipher the words or their meaning or being unable to make sense of the text. Stroke details were recorded from patient notes accounting for stroke laterality, type, and area involved. Ocular treatment details were recorded along with outcome. Reasons for nonattendance at review appointments included death, a move out of area, lost to follow-up, follow-up unwanted, or unknown. 
| Data analysis
| RESULTS
| General demographics
One thousand three hundred and forty-five patients were referred for visual assessment for this study. All were suspected of having visual problems. Nine hundred and fifteen patients were recruited and 430 patients were excluded. Reasons for exclusion included inability/unwilling to provide informed, written consent as required of the ethical approval for this study (n = 259), patients were discharged prior to receiving visual assessment (n = 52), diagnosis was changed to transient ischemic attack or other pathology (n = 54), patients died prior to visual assessment (n = 26), or patients failed to attend for visual assessment (n = 4). It was not possible to obtain full visual information on these excluded patients.
Of 915 patients recruited, 59% (n = 540) were men and 41%
(n = 375) women. Mean age at onset of stroke was 69 years (range 1-94: SD 14 years). One patient was aged 1 year and the range thereafter was 19-94 years. The median age at onset of stroke was 71 years.
Median duration from onset of stroke to initial baseline eye examination was 22 days (0-2543 days), the mean of 40.84 (SD 141.28) days being skewed by three outliers who were referred a number of years after the stroke onset. Stroke lesion was right sided in 448 patients (49%, i.e., right sided brain), left sided in 348 (38%), and bilateral in 119 (13%). Infarcts accounted for 773 cases (84.5%) with the remainder due to hemorrhage.
Overall, 8% (n = 72) had normal visual assessment. Of those formally diagnosed with visual impairment, 45.5% (n = 415) had solely one form of visual impairment: 17% (n = 155) had visual field loss, 20%
(n = 181) had eye movement abnormalities, 2% (n = 17) had visual perceptual difficulties, and 7% (n = 62) had low central vision-whereas 46.5% (n = 423) had multiple visual impairments.
| Central vision
Median visual acuity for each eye was 0.2 logMAR with a mean of 0.26 (SD 0.39, range −0.2-2.5). About 32% (n = 296) had visual acuity of 0.0 logMAR (6/6 Snellen equivalent) or better, 76% had visual acuity of 0.3 logMAR (6/12 Snellen) or better (n = 698), and 86.5% had visual acuity of 0.5 logMAR (6/18 Snellen) or better (n = 792). Three quarters of the cohort required glasses (75.6%, n = 692), 5% had preexistent strabismus and/or amblyopia and 27.4% had coexistent ocular pathology; typically glaucoma, age-related macular degeneration, cataract, and diabetic retinopathy (Table 1) . 
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| Ocular alignment and movement
Manifest strabismus was noted in 18.5% (n = 169) patients of which 3% was long-standing prior to the stroke onset (Table 2A) . Acquired constant exotropia occurred most frequently, p = .001.
Ocular motility abnormalities were documented in 68% (n = 622) patients (Table 2B) ; most frequently saccadic dysmetria (30.4%, n = 278), gaze defects (22.6%, n = 207), and cranial nerve palsies (9.7%, n = 89). A variety of nystagmus types were recorded in 12.2%
(n = 112) with the most common type being pathological end-point nystagmus (Table 2C) .
Normal convergence near point of 6 cm was reported in nearly 39% of patients (n = 354). Reduced near point of convergence less than 8 cm was recorded in nearly 38% (n = 345) and for less than 10 cm in 26.7% (n = 235).
| Lid and pupil function
Normal lid function was evident in 85.9% (n = 786). The remainder had unilateral or bilateral ptosis or lid retraction, with unilateral ptosis being most common (Table 3A) . Normal pupil function was evident in A further seven patients were registered partially sighted.
90.8% (n = 831) with the remainder having varied forms of dilated or miosed pupils (Table 3B ). Relative afferent pupillary defect and anisocoria were the most common forms.
| Visual field loss and visual perception
Over half (52.3%, n = 479) of patients had visual field loss (Table 4) . The most common type of visual field loss was found to be complete (n = 259) and partial (n = 79) homonymous hemianopia and occurring significantly more frequently to the left side than to the right side or bilaterally, p = .001 (t test). Other types included superior or inferior quadrantanopia (n = 73), constricted visual fields (n = 44), scotomas (n = 5), temporal crescent defect (n = 1), and bilateral hemianopia (cortical blindness: n = 1).
Visual inattention was noted in 15% of the cohort (n = 137) whereas other visual perceptual deficits such as visual agnosia, cortical color visual or depth impairment, and acquired alexia were noted in 4.6%.
| Symptoms
Visual symptoms (Table 5) were reported by 84% of patients (n = 766) either as a sole symptom (56%) or combined as two or more visual symptoms (28%). Visual field loss was the most common symptom (45.6%) followed by blurred vision (31.2%), reading difficulty (19.6%), and diplopia (17.3%). Visual field loss was typically reported in the presence of visual field loss, diplopia was typical for ocular alignment and/or motility disorders, whereas blurred vision and reading difficulty were nonspecific symptoms of various ocular diagnoses. Fifty patients had a normal visual examination despite having reported visual symptoms.
| Management
Treatment options were offered to all patients with visual impairment (92%: Table 6 ). Referral for new or updated refraction was most commonly provided (29.3%, n = 247) followed by prisms (12%, n = 101), occlusion (7.8%, n = 66), typoscopes (8.9%, n = 75), and low vision aids (3.8%, n = 32). Advice was offered to almost all patients (99%) and consisted of information about eye and head scanning training, reading strategies, appropriate lighting, visual field awareness, visual inattention awareness, and use of compensatory head posture.
T A B L E 3 Lid and pupil disorders
A Lid function disorders
Unilateral ptosis
Bilateral ptosis Perceptual difficulties inclusive of: depth perception difficulty, alexia, agraphia, photophobia, color perception difficulties.
Unilateral lid retraction
Bilateral lid retraction
| Impact to activities of daily living
Activities of daily living dependent on vision were assessed for patients with and without visual symptoms (Figure 2 ). There was no significant difference between groups, p = .447 (Pearson x 2 test).
| DISCUSSION
This study comprised a subpopulation of stroke survivors; those re- Clearly, focused investigation is required to confirm the diagnosis of many of these disorders, particularly those with more subtle presentation features. Visual symptoms were reported overall by 84% of patients but of a wide variety as reported previously (Rowe, 2013) .
Notably, of 16% who were asymptomatic, many had confirmed visual impairment including substantial hemianopic visual field loss, limited eye movements, and reduced visual acuity. This latter group raises the question of how many stroke survivors with visual impairment may remain undetected where formal vision screening is not undertaken.
This study only recruited those referred with suspected visual impairment and used a screening/referral form to facilitate this. However, as published previously, issues exist with such screening forms particularly where there is reliance on patient-reported visual symptoms to aid identification of suspected visual impairment (Rowe, 2011) . It remains unknown how many patients with visual impairment were undetected because of patient failure to report visual symptoms ei- Given that poststroke visual impairment is estimated at 65% (Hepworth et al., 2015) and in view of the confirmed unmet needs reported by stroke survivors with visual impairment there is an urgent requirement to implement comprehensive, wide-spread screening of stroke survivors to ensure identification of their visual issues. National guidance exists for provision of specialist services on stroke units for poststroke visual impairment with orthoptists being recommended as part of the core acute stroke unit team (British Irish Orthoptic Society, 2016; Intercollegiate Stroke Working Party, 2016) ; services that are proven to be feasible and acceptable for delivery on acute stroke units and neuro-rehabilitation units and which are cost effective (Pollock, Hazelton, & Brady, 2011; . Recent research reports vision screening to be achievable at a median of 3 days post stroke with full visual examinations achieved at a median of 4 days post stroke (Rowe, Hepworth, Hanna, & Howard, 2016) .
The impact of visual impairment is clear with considerable issues
relating to driving, activities of daily living, mobilization, social engagement among others . Given the high rate of visual symptoms and known impact, access to appropriate management options at the early acute poststroke stage is important. A wide variety of management options were provided in this study, many of which are evidence based as to their efficacy (Adler, 2002; Carruthers, Kennedy, & Bagaric, 1990; Firth & Whittle, 1994; Pollock et al., 2011 Pollock et al., , 2011a Pollock et al., , 2011b Pollock et al., , 2012 Thurtell & Leigh, 2010) . It is important to note that, for advice on compensatory mechanisms, these are frequently of benefit to patients despite lacking an evidence base through case control or randomized trials. It is of further importance to recognize these management options are not 'one size fits all' but require targeting to the type of visual impairment and individual symptoms. Ensuring referral to specialist services will direct the stroke survivor to correct and appropriate treatment, whilst minimizing risks from inappropriate therapies provided by staff lacking the requisite training and/or knowledge.
| CONCLUSIONS
The Vision In Stroke study is, to our knowledge, the first large-scale observation study of poststroke visual impairment. In this population of stroke survivors referred with suspected visual impairment, prevalence of visual impairment was 92%. There are a wide range of visual disorders that occur following stroke and, frequently, give rise to visual symptoms. There are equally a wide variety of treatment options available for these individuals. We recommend that all stroke survivors require screening for visual impairment in the early days poststroke onset and warrant referral for specialist assessment and targeted treatment specific to the type of visual impairment. 
